N. Raman et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 96 (2012) 698–708
707
Table 6
through minor groove binding. When irradiated at 360 nm, metal
complexes can efficiently cleave the plasmid pUC19 DNA. The
mechanism studies of photoactivated cleavage reveal that singlet
Minimum inhibitory concentration values of the synthesized compounds against the
growth of five fungi (MIC in lg/mL).
oxygen (1O2) and superoxide anion radical (Oꢀꢀ) may play an
Compound
A. niger
F. solani
C. lunata
R. bataicola
C. albicans
2
L1
22.6
24.8
8.0
9.1
8.9
9.2
11.5
9.3
25.5
27.6
7.3
10.3
8.2
10.5
10.1
11.7
1.6
23.3
25.7
8.4
7.4
10.4
7.9
10.5
10.3
1.2
21.5
22.3
8.1
25.9
24.1
10.2
8.1
important role in the photocleavage. However, these observations
and a more extensive study would be necessary in order to assert
that the complexes act as cleavage agents. These results should be
considered as promising lead compounds for the development of
targeted drugs for cancer treatment. The Schiff base ligands and
their complexes show antimicrobial activity against selected kinds
of bacteria and fungi, results of this work can show that the ap-
proach of coordinating 4-aminoantipyrine derivatives with phar-
macologically interesting metals such as copper, nickel and zinc
could be a suitable strategy to develop novel therapeutic tools
for the medical treatment.
L2
[CuL1]
[NiL1]
[ZnL1]
[CuL2]
[NiL2]
[ZnL2]
Nystatin
7.5
10.2
11.5
10.5
12.2
1.0
9.5
10.1
11.3
11.0
1.5
1.1
using either a biocation or a metallic ion exhibiting inhibitory
properties as well as a ligand that displays such activity. On the
other hand, important characteristics that can be correlated with
a good antimicrobial activities are as follows: (i) the presence of
uncoordinated groups that permits the recognition by living organ-
ism and enhances the solubility (hydrophilic or hydrophobic) (ii)
the ability to form hydrogen bonding with a counter anion or sol-
vent molecules (iii) the dimension and nature of the substituted
groups attached to the donor atoms that influence the ligand lipo-
philicity and membrane permeability, controlling thus the cell
penetration (iv) the small coordination number or the presence
of some ligands easy to be removed in interaction with biomole-
cules (v) a stereochemistry that allows a favorable three-dimen-
sional interaction with biomolecules and (vi) a high kinetic and
thermodynamic stability in order to control the dissociation in
the acidic medium from the stomach, the metabolization in san-
Acknowledgments
The authors express their sincere thanks to the College Manag-
ing Board, Principal and Head of the Department of Chemistry,
VHNSN College, Virudhunagar, India for providing necessary re-
search facilities. N.R. thanks the University Grants Commission
(UGC), New Delhi for financial assistance.
References
[1] S. Budagumpi, N.V. Kulkarni, G.S. Kurdekar, M.P. Sathisha, V.K. Revankar, Eur. J.
Med. Chem. 45 (2010) 455–462.
[2] P.K. Mascharak, Coord. Chem. Rev. 225 (2002) 201–214.
[3] N. Shahabadi, S. Kashanian, F. Darabi, Eur. J. Med. Chem. 45 (2010) 4239–4245.
[4] N. Raman, S. Sobha, Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 85 (2012)
223–234.
guine flux and to induce
biomolecules.
a low substitution rate with the
[5] E.J. Gao, L. Wang, M.C. Zhu, L. Liu, W.Z. Zhang, Eur. J. Med. Chem. 45 (2010)
311–316.
[6] B.A. Chabner, T.G. Roberts, Nat. Rev. Cancer 5 (2005) 65–72.
[7] L.H. Hurley, Nat. Rev. Cancer 2 (2002) 188–200.
[8] B. Rosenberg, L. Vancamp, T. Krigas, Nature 205 (1965) 698–699.
[9] B. Rosenberg, L. Vancamp, J.E. Trosko, V.H. Mansour, Nature 222 (1969) 385–
386.
[10] M.J.F. Schepman, J.L. Van der veer, J.H.J. Den hartog, P.H.M. Lohman, J. Reedijk,
Biochemistry 24 (1985) 707–713.
[11] M.A. Fuertes, C. Alonso, J.M. Perez, Chem. Rev. 103 (2003) 645–662.
[12] Y.P. Ho, S.C.F. Au-Yeung, K.K.W. To, Med. Res. Rev. 23 (2003) 633–655.
[13] Z.H. Siddik, Oncogene 22 (2003) 7265–7279.
Antifungal activity
To provide a medicinal scope in the field of bioinorganic chem-
istry, consequently, the metal complexes synthesized have been
evaluated for their antifungal actions. The antifungal tests were
carried out using the disk diffusion method. The Schiff base ligands
and their metal complexes also screened in vitro in order to find
out the antifungal activity against Aspergillus niger, Fusarium solani,
Culvularia lunata, Rhizoctonia bataicola and Candida albicans. The re-
sults of the antifungal studies are presented in Table. 6 which re-
veals that the metal complexes are toxic than the free ligand
against the same organisms. The increase in the antifungal activity
of the metal complexes inhibits multiplication process of the mi-
crobes by blocking their active sites. Such increased activity on me-
tal chelation can be explained on the basis of Tweedy’s chelation
theory [51]. The chelation also increases the lipophilic nature and
an interaction between the metal ion and the lipid is favored. This
may lead to the breakdown of the permeability barrier of the cell
resulting in interference with the normal cell processes. While che-
lation is not the only factor for antimicrobial activity, it is an intri-
cate blend of several aspects such as nature of the metal ion and
the ligand, the geometry of the metal complexes, the lipophilicity,
the presence of co-ligands, the steric and pharmacokinetic factors
[52]. The synthesized compounds having amino acid moieties also
show good activity.
[14] A. Silvestri, G. Barone, G. Ruisi, M.T. Giudice, S. Tumminello, J. Inorg. Biochem.
98 (2004) 589–594.
[15] S. Apelgot, J. Coppy, A. Fromentin, E. Guille, M.F. Poupon, A. Roussel, Anticancer
Res. 6 (1986) 159–164.
[16] I.E. Dreosti, Mutat. Res. 475 (2001) 161–167.
[17] K.H. Falchuk, Mol. Cell. Biochem. 188 (1998) 41–48.
[18] M. Patil, R. Hunoor, K. Gudasi, Eur. J. Med. Chem. 45 (2010) 2981–2986.
[19] S. Sobha, N. Raman, Int. J. Pharm. Biol. Sci. 3 (2012) 116–123.
[20] J. Marmur, J. Mol. Biol. 3 (1961) 208–218.
[21] A. Wolfe, G.H. Shimer, T. Meehan, Biochemistry 26 (1987) 6392–6396.
[22] Z.H. Chohan, H. Pervez, K.M. Khan, A. Rauf, G.M. Maharvi, C.T. Supuran, J.
Enzym. Inhib. Med. Chem. 19 (2004) 85–90.
[23] Z.H. Chohan, H. Pervez, A. Rauf, A. Scozzafava, C.T. Supuran, J. Enzym. Inhib.
Med. Chem. 17 (2002) 117–122.
[24] Z.H. Chohan, S. Kausar, Met. Based Drugs 7 (2000) 17–22.
[25] T.A. Reena, M.R. Prathapachandra Kurup, Spectrochim. Acta Part
Biomol. Spectrosc. 76 (2010) 322–327.
[26] P. Kamalakannan, D. Venkappayya, Russ. J. Coord. Chem. 28 (2002) 423–433.
[27] D. Kivelson, R. Neiman, J. Chem. Phys. 35 (1961) 149–155.
[28] F.A. Cotton, G. Wilkinson, Advanced Inorganic Chemistry, A Comprehensive
Text, fourth ed., John Wiley and Sons, New York, 1986.
A Mol.
[29] J. Muller, K. Felix, C. Maichle, E. Lengfelder, J. Strahle, U. Weser, Inorg. Chim.
Acta 233 (1995) 11–19.
[30] V.P. Daniel, B. Murukan, B. Sindhu Kumari, K. Mohanan, Spectrochim. Acta Part
A Mol. Biomol. Spectrosc. 70 (2008) 403–410.
[31] S.M.M. Romanowski, F. Tormena, V.A. Santos, M.F. Hermann, A.S. Mangrich, J.
Braz. Chem. Soc. 15 (2004) 897–903.
Conclusion
Six new biologically active 4-aminoantipyrine derived Schiff
base ligands and their Cu(II), Ni(II) and Zn(II) complexes have been
synthesized and characterized by spectral and analytical data. The
interaction of metal complexes with DNA has been investigated.
These results show that all the complexes interact with DNA
[32] B.J. Hathaway, D.E. Billing, Coord. Chem. Rev. 5 (1970) 143–207.
[33] H.R. Geremann, J.R. Swalen, J. Chem. Phys. 36 (1962) 3221–3233.
[34] B.J. Hathaway, Struct. Bonding 14 (1973) 49–67.
[35] A. Krezela, J. Lisowski, J. Inorg. Biochem. 107 (2012) 1–5.
[36] X.-L. Zhaoa, M.-J. Hana, A.-G. Zhanga, K.-Z. Wang, J. Inorg. Biochem. 107 (2012)
104–110.